Cargando…
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
COVID-19 is associated with a high incidence of thrombotic complications, which can be explained by the complex and unique interplay between coronaviruses and endothelial cells, the local and systemic inflammatory response, and the coagulation system. Empirically, an intensified dose of thrombosis p...
Autores principales: | Leentjens, Jenneke, van Haaps, Thijs F, Wessels, Pieter F, Schutgens, Roger E G, Middeldorp, Saskia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078884/ https://www.ncbi.nlm.nih.gov/pubmed/33930350 http://dx.doi.org/10.1016/S2352-3026(21)00105-8 |
Ejemplares similares
-
Focus on coronavirus disease 2019 associated coagulopathy
por: Yang, Xiang-Hong, et al.
Publicado: (2020) -
Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
por: Limbruno, Ugo, et al.
Publicado: (2020) -
The Applied Data Analytics in Medicine Program: Lessons Learned From Four Years’ Experience With Personalizing Health Care in an Academic Teaching Hospital
por: Haitjema, Saskia, et al.
Publicado: (2022) -
The renin–angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications
por: Diamond, Betty
Publicado: (2020) -
Implications of COVID-19−associated Coagulopathy on Reconstructive Surgery: A Case of Ongoing Tissue Necrosis
por: Dugue, David, et al.
Publicado: (2020)